55 private COVID hospitals get Remdesivir drug
Updated:
Updated:
Two injections being supplied for each patient
Share Article
Two injections being supplied for each patient
The East Godavari district authorities on Monday supplied 4,086 Remdesvir injections to 55 private hospitals treating the COVID-19 patients.
“There is no shortage of Remdesivir. As many as 4,086 injections have been supplied, ensuring availability of two injections to each patient admitted to the designated private hospitals for the COVID treatment”, said Collector D. Muralidhar Reddy. In the past week, over 18,000 Remdesivir injections had been supplied to private hospitals.
“We have a sufficient number of Remdesivir injections in our stores. However, the injection is issued to private hospitals only if they return the empty injection bottles and provide data of the receiver for audit,” said Mr. Reddy.
CDSCO approves antibody cocktail drug for restricted emergency use to treat mild Covid-19 cases
CDSCO approves use of antibodies cocktail drug (Casirivimab and Imdevimab) for restricted emergency use to treat mild to moderate Covid-19 in adults and paediatric patients.
advertisement
Health workers inspect Covid-19 patients at a hospital in New Delhi. (Photo credit: PTI).
The Indian regulatory body, Central Drugs Standards Control Organisation (CDSCO), has approved the use of antibodies cocktail drug (Casirivimab and Imdevimab), for restricted emergency used to treat mild to moderate Covid-19 in adults and paediatric patients (12 years or weighing more than at least 40 kg).
Antibodies Cocktail Drug can be a game-changer in Covid-19 treatment, especially when these are recommended to be given at the early stages of laboratory-confirmed SARS-CoV-2 infection positive result. Theis is preferebly administered within 10 days of symptoms onset.
URL copied
No proof of Remdesivir s effectiveness in COVID patients
Ganga Ram hospital Chairperson Dr. DS Rana on Tuesday said that Remdesivir is also being considered to be dropped from COVID-19 treatment soon as there is no evidence of its effectiveness in treating COVID-19 patients. This move comes after, the use of convalescent plasma has been dropped from the recommended treatment protocols for COVID -19, according to an advisory from the Indian Council of Medical Research (ICMR).
Ganga Ram hospital Chairperson Dr. DS Rana further said, In plasma therapy, we give a pre-forwarded antibody to someone who has been infected before, so that the antibody can fight with the virus. Antibodies usually form when the coronavirus attacks. We have seen in the last year that giving plasma does not make any difference in the condition of the patient and other people. Also, it is not easily available. Plasma therapy was started on a scientific basis and has been discontinued on th
VIRAL: Man mistakenly calls Remdesivir as Remo D'souza, choreographer reacts - For the uninitiated, Remdesivir is a broad-spectrum antiviral medication that is being used during the Covid-19 crisis.